![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A01K 67/027 | (2006.01) |
C12N 15/90 | (2006.01) | ||
C12N 15/85 | (2006.01) | ||
C07K 16/00 | (2006.01) |
(11) | Number of the document | 3407709 |
(13) | Kind of document | T |
(96) | European patent application number | 17863293.1 |
Date of filing the European patent application | 2017-11-03 | |
(97) | Date of publication of the European application | 2018-12-05 |
(45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
(46) | Date of publication of the claims translation | 2020-10-12 |
(86) | Number | PCT/US2017/060006 |
Date | 2017-11-03 |
(87) | Number | WO 2018/128691 |
Date | 2018-07-12 |
(30) | Number | Date | Country code |
201662417845 P | 2016-11-04 | US | |
201762567932 P | 2017-10-04 | US |
(72) |
GUO, Chunguang, US
HARRIS, Faith, US
VORONINA, Vera, US
MCWHIRTER, John, US
LEVENKOVA, Natasha, US
MACDONALD, Lynn, US
TU, Naxin, US
MURPHY, Andrew, J., US
|
(73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6706,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Gyvūnai, išskyrus žmogų, turintys sukonstruotą imunoglobulino lambda lengvosios grandinės lokusą |
NON-HUMAN ANIMALS HAVING AN ENGINEERED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN LOCUS |
Payment date | Validity (years) | Amount | |
2024-10-22 | 8 | 185.00 EUR |
2025-11-03 |